Hospital and Medical Care Days in Pancreatic Cancer
Authors:
- 27 March 2012
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 19 (8) , 2435-2442
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- End‐of‐life care in Medicare beneficiaries dying with pancreatic cancerCancer, 2011
- Resection Benefits Older Adults with Locoregional Pancreatic Cancer Despite Greater Short‐Term Morbidity and MortalityJournal of the American Geriatrics Society, 2011
- Preoperative Factors Predict Perioperative Morbidity and Mortality After PancreaticoduodenectomyAnnals of Surgical Oncology, 2011
- Quality of life after adjuvant intra‐arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancerCancer, 2009
- Validation of a prediction rule to maximize curative (R0) resection of early-stage pancreatic adenocarcinomaHPB, 2009
- A randomised Phase III trial of glufosfamide compared with best supportive care in metastatic pancreatic adenocarcinoma previously treated with gemcitabineEuropean Journal of Cancer, 2009
- Longitudinal quality of life data can provide insights on the impact of adjuvant treatment for pancreatic cancer—Subset analysis of the ESPAC‐1 dataInternational Journal of Cancer, 2009
- National Failure to Operate on Early Stage Pancreatic CancerAnnals of Surgery, 2007
- Comparing Hospice and Nonhospice Patient Survival Among Patients Who Die Within a Three-Year WindowJournal of Pain and Symptom Management, 2007
- Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-upSurgery, 2006